Biotech Business - April 3, 2023
Oncopeptides receives a research grant from Vinnova
Oncopeptides has received a research grant of 3 million SEK from Sweden’s Innovation Agency (Vinnova), to explore the development of new treatment options for glioblastoma, an aggressive and incurable form of brain cancer. The grant enables exploratory research to better understand the potential of the PDC platform in solid tumors such as glioblastoma. “We are […]
Financing - March 30, 2023
Vakona receives 14 million SEK investment
Vakona has been given a capital injection from five investors to help it develop a new drug to treat acne. “This is a significant investment for us, as now we can continue with our product development,” says Gabriella Persson, CEO of Vakona. Three of the investors, Stoaf III SciTech, Partnerinvest Norr and Phase2Phase Biopharma, have […]
Biotech Business - March 22, 2023
Aqilion to recieve 20.1 million SEK
In order to strengthen the company’s liquidity and to ensure the continued development of the company’s pipeline, on July 27, 2022 the Aqilion Board of Directors decided on to carry out an issue with priority for existing owners. The issue was carried out during the third quarter of 2022 as an issue of units, which […]
Biotech Business - March 21, 2023
FluoGuide awarded prestigious grant
Innovation Fund Denmark (Innovationsfonden) has awarded its largest grant for research and development of photothermal therapy to a consortium of four academic groups and FluoGuide. The grant valued at DKK 49.1 million (approx. EUR 6.6 million or SEK 75.6 million) structured through a combination of a cash contribution from Innovation Fund Denmark (50%) and a […]
Biotech Business - February 22, 2023
Hemab Therapeutics raises 135 million USD
Hemab Therapeutics has announced the closing of an oversubscribed Series B financing. The round was led by Access Biotechnology with participation from new investors Deep Track Capital, Avoro Ventures, Invus, Rock Springs Capital, and Maj Invest Equity. All current investors including HealthCap, Novo Holdings, and RA Capital Management also invested. Part of HealthCap’s VIII fund […]
Biotech Business - February 15, 2023
Valo Therapeutics secures 2.23 million EUR
The company has secured funding from the European Innovation Council (EIC) for a project to progress the company’s PeptiCHIP technology. PeptiCHIP rapidly identifies a tumor’s antigen presentation profile to drive development of novel personalized immunotherapies. Read more: Reinventing immunotherapy – Valo Therapeutics NLS Star 2022 The project, which will be fully funded by the EIC with […]
